$604M
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | AVR Anteris Technologies Global | 5.5M | +3.0% | $55M | 9.0% |
| 2 | COR Cencora Inc | 173,588 | +72.0% | $49M | 8.1% |
| 3 | MMS Maximus Inc | 715,267 | −7.0% | $38M | 6.4% |
| 4 | ALLO Allogene Therapeutics Inc | 13.3M | — | $28M | 4.6% |
| 5 | GMED Globus Med Inc | 301,816 | — | $24M | 3.9% |
| 6 | GSK Gsk Plc | 436,700 | +13.2% | $23M | 3.8% |
| 7 | TYRA Tyra Biosciences Inc | 695,315 | +14.8% | $22M | 3.7% |
| 8 | WAY Waystar Hldg Corp | 925,834 | −43.6% | $19M | 3.1% |
| 9 | IDYA Ideaya Biosciences Inc | 480,383 | — | $18M | 3.0% |
| 10 | ORKA Oruka Therapeutics Inc | 177,118 | +33.7% | $17M | 2.8% |
| 11 | CI The Cigna Group | 57,750 | — | $16M | 2.6% |
| 12 | SNY Sanofi Sa | 364,200 | +52.0% | $16M | 2.6% |
| 13 | ICLR Icon Pub Ltd Co | 88,186 | −71.2% | $15M | 2.5% |
| 14 | VTRS Viatris Inc | 954,299 | — | $15M | 2.5% |
| 15 | CROSS CTRY HEALTHCARE INC Cross Ctry Healthcare Inc | 1.1M | +0.0% | $15M | 2.4% |
| 16 | RAPP Rapport Therapeutics Inc | 307,657 | −16.1% | $13M | 2.1% |
| 17 | ABT Abbott Laboratories | 128,656 | −31.0% | $12M | 1.9% |
| 18 | CELC Celcuity Inc | 110,022 | −43.2% | $12M | 1.9% |
| 19 | ZBH Zimmer Biomet Holdings Inc | 131,445 | +109.9% | $11M | 1.9% |
| 20 | REGN Regeneron Pharmaceuticals | 18,000 | — | $11M | 1.9% |
| 21 | BMY Bristol-Myers Squibb Co | 193,500 | — | $11M | 1.8% |
| 22 | MDT Medtronic Plc | 142,500 | — | $11M | 1.8% |
| 23 | VIR Vir Biotechnology Inc | 1.1M | −28.2% | $11M | 1.8% |
| 24 | SENS Senseonics Hldgs Inc | 1.6M | +1275.6% | $9M | 1.5% |
| 25 | EYPT Eyepoint Inc | 623,130 | −13.7% | $9M | 1.5% |
| 26 | CYBIN INC Cybin Inc | 1.3M | — | $9M | 1.4% |
| 27 | ANIP Ani Pharmaceuticals Inc | 97,305 | −63.4% | $8M | 1.3% |
| 28 | TARA Protara Therapeutics Inc | 1.9M | −2.4% | $7M | 1.2% |
| 29 | RLMD Relmada Therapeutics Inc | 1.0M | +4.0% | $7M | 1.1% |
| 30 | TNGX Tango Therapeutics Inc | 208,500 | — | $7M | 1.1% |
| 31 | AQST Aquestive Therapeutics Inc | 1.5M | −22.7% | $6M | 1.0% |
| 32 | DNTH Dianthus Therapeutics Inc | 59,254 | −84.0% | $6M | 1.0% |
| 33 | SION Sionna Therapeutics Inc | 127,808 | −56.6% | $6M | 0.9% |
| 34 | OCUL Ocular Therapeutix Inc | 539,493 | −44.3% | $5M | 0.9% |
| 35 | ZBIO Zenas Biopharma Inc | 208,557 | −37.1% | $5M | 0.9% |
| 36 | DRUG Bright Minds Biosciences Inc | 73,952 | −14.1% | $5M | 0.9% |
| 37 | OKUR Onkure Therapeutics Inc | 1.1M | +0.0% | $5M | 0.8% |
| 38 | SVRA Savara Inc | 617,675 | +0.6% | $4M | 0.6% |
| 39 | PMVP Pmv Pharmaceuticals Inc | 2.6M | −14.4% | $4M | 0.6% |
| 40 | AVAH Aveanna Healthcare Hldgs Inc | 369,036 | — | $3M | 0.5% |
| 41 | OVID Ovid Therapeutics Inc | 1.0M | −19.7% | $3M | 0.4% |
| 42 | IMNM Immunome Inc | 124,168 | −24.8% | $3M | 0.4% |
| 43 | ANTX An2 Therapeutics Inc | 529,933 | −19.4% | $3M | 0.4% |
| 44 | SER Serina Therapeutics Inc | 1.0M | +0.0% | $2M | 0.3% |
| 45 | ALGS Aligos Therapeutics Inc | 327,237 | +0.0% | $2M | 0.3% |
| 46 | IBIO Ibio Inc | 904,268 | +0.0% | $2M | 0.3% |
| 47 | XLO Xilio Therapeutics Inc | 152,464 | +0.0% | $1M | 0.2% |
| 48 | AORT Artivion Inc | 48,481 | — | $1M | 0.2% |
| 49 | BBOT Bridgebio Oncology Therapeut | 130,628 | +0.0% | $995,385 | 0.2% |
| 50 | TELA Tela Bio Inc | 636,300 | +0.0% | $477,225 | 0.1% |